Neurogene Inc. (NASDAQ:NGNE)
| Market Cap | 435.20M+6.6% |
| Revenue (ttm) | 0 |
| Net Income | -111.11M-31.7% |
| EPS | -5.51-19.0% |
| Shares Out | 15.80M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 94,471.685 |
| Open | 28.00 |
| Previous Close | 25.87 |
| Day's Range | 26.50 - 28.97 |
| 52-Week Range | 15.93 - 43.66 |
| Beta | 1.96 |
| Analysts | Buy |
| Price Target | 72.00(+161.44%) |
| Earnings Date | Nov 12, 2026 |
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
About NGNE
Neurogene Inc. is dedicated to engineering transformative genetic treatments for individuals and their families grappling with debilitating neurological conditions. Its current pipeline prominently features two key investigational therapies: NGN-401, an AAV9 gene therapy specifically targeting Rett syndrome, and NGN-101, which is being developed to address neuronal ceroid lipofuscinosis subtype 5 (Batten disease). The company's operations are based in New York, New York.
$NGNE stock is featured in our Insider Trades datasets.
→ All Stock ListsRecently reported changes in NGNE holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by NGNE's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
NGNE Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New NGNE patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to NGNE from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in NGNE
| ETF | Est. Holding Size |
|---|---|
| IWMiShares Russell 2000 ETF | $10.59M |
| XBIState Street SPDR S&P Biotech ETF | $7.12M |
| IBBiShares Biotechnology ETF | $3.12M |
| FESMFidelity Enhanced Small Cap ETF | $2.77M |
| VTWOVanguard Russell 2000 ETF | $2.36M |
| IWCiShares Micro-Cap ETF | $1.27M |
Estimated from each fund’s disclosed top holdings × AUM
NGNE Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from NGNE’s recent data — informational, not investment advice